HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	383.87	391.86	382.83	311	309.16	214.93
Other Revenue	10.48	10.48	11.57	9.39	8.55	6.93
Revenue	394.35	402.34	394.41	320.39	317.71	221.86
Revenue Growth (YoY)	-1.22%	2.01%	23.10%	0.84%	43.20%	-14.38%
Cost of Revenue	145.31	145.16	149.41	118.14	98.55	76.4
Gross Profit	249.04	257.18	244.99	202.26	219.16	145.46
Selling, General & Admin	155.37	160.69	140.05	118.76	99.87	69.19
Research & Development	44.14	45.47	46.32	38.11	31.23	23.04
Other Operating Expenses	8.4	6.47	4.83	3.64	3.32	2.48
Operating Expenses	208.07	213.02	191.7	160.25	134.83	95.23
Operating Income	40.97	44.16	53.3	42.01	84.33	50.22
Interest Expense	-2.97	-2.71	-2.53	-1.92	-1.24	-1.89
Interest & Investment Income	0.67	0.89	3.4	6.95	13.08	15.3
Currency Exchange Gain (Loss)	-0.53	-0.53	-0.01	-0.15	-0.46	0.01
Other Non Operating Income (Expenses)	0.01	-0.36	-0.27	-0.18	0	-0
EBT Excluding Unusual Items	38.15	41.46	53.89	46.71	95.72	63.65
Gain (Loss) on Sale of Investments	-	-	0.43	0.22	0.01	-
Gain (Loss) on Sale of Assets	-0.75	-0.75	0.03	-0.47	-0.08	-0.37
Asset Writedown	-1.1	-1.1	-	-	-	-
Other Unusual Items	2.9	1.43	2.28	0.02	3.48	1.82
Pretax Income	39.21	41.03	56.63	46.48	99.13	65.1
Income Tax Expense	4.57	4.23	9.29	4.83	12.93	8.49
Net Income	34.63	36.8	47.33	41.65	86.19	56.62
Net Income to Common	34.63	36.8	47.33	41.65	86.19	56.62
Net Income Growth	-24.02%	-22.24%	13.64%	-51.68%	52.24%	-11.31%
Shares Outstanding (Basic)	60	62	63	63	62	47
Shares Outstanding (Diluted)	61	63	64	63	62	47
Shares Change (YoY)	-4.88%	-0.79%	1.35%	2.50%	30.49%	-0.22%
EPS (Basic)	0.58	0.59	0.75	0.66	1.40	1.20
EPS (Diluted)	0.57	0.58	0.74	0.66	1.40	1.20
EPS Growth	-20.11%	-21.62%	12.12%	-52.86%	16.67%	-11.11%
Free Cash Flow	-15.61	-54.15	-75.34	-161.9	-63.09	1.21
Free Cash Flow Per Share	-0.26	-0.85	-1.18	-2.56	-1.02	0.03
Dividend Per Share	0.300	0.300	0.400	0.300	0.530	0.300
Dividend Growth	-25.00%	-25.00%	33.33%	-43.40%	76.67%	-
Gross Margin	63.15%	63.92%	62.12%	63.13%	68.98%	65.56%
Operating Margin	10.39%	10.98%	13.51%	13.11%	26.54%	22.64%
Profit Margin	8.78%	9.15%	12.00%	13.00%	27.13%	25.52%
Free Cash Flow Margin	-3.96%	-13.46%	-19.10%	-50.53%	-19.86%	0.55%
EBITDA	81.62	83.31	86.41	68.95	104.06	65.62
EBITDA Margin	20.70%	20.71%	21.91%	21.52%	32.76%	29.58%
D&A For EBITDA	40.65	39.14	33.12	26.94	19.73	15.4
EBIT	40.97	44.16	53.3	42.01	84.33	50.22
EBIT Margin	10.39%	10.98%	13.51%	13.11%	26.54%	22.64%
Effective Tax Rate	11.67%	10.31%	16.41%	10.39%	13.05%	13.04%
Revenue as Reported	394.35	402.34	394.41	320.39	317.71	221.86
Advertising Expenses	-	10.05	9.61	8.73	6.51	5.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.